Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Total Liabilities: 2017-2024

Historic Total Liabilities for Dianthus Therapeutics (DNTH) over the last 6 years, with Dec 2024 value amounting to $21.5 million.

  • Dianthus Therapeutics' Total Liabilities rose 89.55% to $31.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.0 million, marking a year-over-year increase of 89.55%. This contributed to the annual value of $21.5 million for FY2024, which is 104.38% up from last year.
  • Dianthus Therapeutics' Total Liabilities amounted to $21.5 million in FY2024, which was up 104.38% from $10.5 million recorded in FY2023.
  • Over the past 5 years, Dianthus Therapeutics' Total Liabilities peaked at $21.5 million during FY2024, and registered a low of $9.5 million during FY2022.
  • For the 3-year period, Dianthus Therapeutics' Total Liabilities averaged around $13.8 million, with its median value being $10.5 million (2023).
  • Data for Dianthus Therapeutics' Total Liabilities shows a peak YoY soared of 104.38% (in 2024) over the last 5 years.
  • Over the past 3 years, Dianthus Therapeutics' Total Liabilities (Yearly) stood at $9.5 million in 2022, then grew by 11.43% to $10.5 million in 2023, then soared by 104.38% to $21.5 million in 2024.